Cargando…

A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients

OBJECTIVES: To develop a nomogram for estimating the glycated haemoglobin (HbA1c) response to different dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetes. DESIGN: A systematic review and meta-analysis of randomised controlled trials (RCTs) of DPP-4 inhibitors (vildagliptin, sitagliptin, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Katherine, Chiodini, Paolo, Maiorino, Maria Ida, Capuano, Annalisa, Cozzolino, Domenico, Petrizzo, Michela, Bellastella, Giuseppe, Giugliano, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336462/ https://www.ncbi.nlm.nih.gov/pubmed/25687897 http://dx.doi.org/10.1136/bmjopen-2014-005892

Ejemplares similares

Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials
por: Esposito, Katherine, et al.
Publicado: (2014)

A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses
por: Esposito, Katherine, et al.
Publicado: (2015)

Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944
por: Maiorino, Maria Ida, et al.
Publicado: (2013)

Long-Term Effect of Mediterranean-Style Diet and Calorie Restriction on Biomarkers of Longevity and Oxidative Stress in Overweight Men
por: Esposito, Katherine, et al.
Publicado: (2010)

Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
por: Giugliano, Dario, et al.
Publicado: (2019)

ODP163 Association of HbA1c and Comfort with Diabetes Self-Management Among Adolescents and Young Adults with Type 1 Diabetes
por: Onwukwe, Obichi, et al.
Publicado: (2022)

Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-analysis of randomized controlled trials
por: Esposito, Katherine, et al.
Publicado: (2012)

Drug titration patterns and HbA(1c) levels in type 2 diabetes
por: Ross Maclean, J, et al.
Publicado: (2009)

Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
por: Giugliano, Dario, et al.
Publicado: (2011)

Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
por: Longo, Miriam, et al.
Publicado: (2020)

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
por: Giugliano, Dario, et al.
Publicado: (2021)

Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
por: Giugliano, Dario, et al.
Publicado: (2022)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
por: Maiorino, Maria Ida, et al.
Publicado: (2021)

Glycated Haemoglobin (HbA1c) Variations in Nondiabetics With Nutritional Anemia
por: Pilla, Rakesh, et al.
Publicado: (2020)

Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects
por: Bellastella, Giuseppe, et al.
Publicado: (2016)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
por: Capuano, Annalisa, et al.
Publicado: (2013)

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
por: Longo, Miriam, et al.
Publicado: (2020)

SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
por: Giugliano, Dario, et al.
Publicado: (2021)

The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes
por: Katwal, Prakash C, et al.
Publicado: (2020)

The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy
por: Almutairi, Noura M, et al.
Publicado: (2021)

ODP169 Challenges with use of HbA1C for Evaluation of Blood Glucose Control
por: Maletkovic, Jelena
Publicado: (2022)

THU253 The Hemoglobin Wayne Variant And Association With Falsely Elevated HbA1c
por: Mulpuri, Neha, et al.
Publicado: (2023)

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
por: Giugliano, Dario, et al.
Publicado: (2021)

European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events
por: di Mauro, Gabriella, et al.
Publicado: (2022)

Association Between Raised HbA1c Levels and Hemorrhagic Transformation in Patients With Ischemic Stroke
por: Afzal, Benish, et al.
Publicado: (2021)

Assessment of Glycemic Control in Patients With Diabetes in Northern Sudan Using Calculated HbA1c
por: Abdel bagi, Omer, et al.
Publicado: (2022)

Correlation Between HbA1c Levels and Mortality Rates in Hospitalized COVID-19 Patients
por: Bhagat, Ankur, et al.
Publicado: (2022)

PSUN317 IL-3 is associated with HbA1c and Serum Lipids in African Americans
por: Wamble, Ezekial, et al.
Publicado: (2022)

Anti-Pituitary Antibodies and Hypogonadotropic Hypogonadism in Type 2 Diabetes: In Search of a Role
por: Bellastella, Giuseppe, et al.
Publicado: (2013)

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
por: Longo, Miriam, et al.
Publicado: (2019)

Cross-sectional comparison of point-of-care with laboratory HbA(1c) in detecting diabetes in real-world remote Aboriginal settings
por: Marley, Julia V, et al.
Publicado: (2015)

THU322 Lower HbA1c Is Associated With Lower In-Hospital Mortality In Patients With COVID-19
por: Tsikala Vafea, Maria, et al.
Publicado: (2023)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

DPP-4 inhibitor treatment: β-cell response but not HbA(1c) reduction is dependent on the duration of diabetes
por: Kozlovski, Plamen, et al.
Publicado: (2017)

Diabetes and sexual dysfunction: current perspectives
por: Maiorino, Maria Ida, et al.
Publicado: (2014)

Lifestyle modifications and erectile dysfunction: what can be expected?
por: Maiorino, Maria Ida, et al.
Publicado: (2015)

Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047
por: Bellastella, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aidsdkcfavu4utfkdhtdsf0n0a